The Barts and The London Cancer Centre seeks excellence in patient care and cancer research.
We’re passionate about caring for our patients, and this website is designed to give you an insight into the care that we provide. Whether you’re visiting us for diagnosis or treatment and support, our team of specialists are here to support you.
Barts and The London Cancer Centre is at the forefront of cancer research and we are continually pushing the boundaries to develop new and successful treatments.
Many of our team of specialists also work as scientists to research and investigate innovative treatments and technologies. We are leaders in our field based on our close working partnerships and collaborations with The Institute of Cancer and Cancer Research UK Clinical Centre at Barts and The London School of Medicine and Dentistry. Here, doctors and staff have a comprehensive knowledge of cancer management in adults and children and the centre is responsible for contributing towards improvements in the clinical management and treatment of most types of cancer.
Our research teams specialize in ‘translational oncology’ that aims to make the research undertaken in the laboratory translate into clinical trials and the development of novel treatments for patients.
Our strong combination of scientific and clinical excellence has been recognized by the Department of Health and National Charity, Cancer Research UK, with the award of £2 million to establish an Experimental Cancer Medicine Centre. This will speed up the introduction of new cancer drugs and treatments and keep us at the forefront of international efforts to develop new treatments for all types of cancer.
The centre, one of a network around the UK, aims to build on our world-renowned expertise in clinical care and basic research. The pioneering centre, based at Barts, investigates how the latest scientific discoveries and cancer treatments work when tested on patients. Working in partnership with Barts and The London School of Medicine and Dentistry, the investment means treatments will be developed for use in the NHS as quickly as possible and that our patients will be some of the first to benefit from new therapies.
Examples of research work undertaken by our clinicians
Blood and lymph gland cancer
Cancer Immunotherapy Group – led by Professor John Gribben
Aims to develop immunotherapy approaches for the treatment of cancer, including stem cell transplantation; and to identify tumour antigens (substances that trigger the immune system to fight cancer) with particular emphasis on B-cell lymphoid malignancies.
We participate in national and international chemotherapy trials such as intraperiteonal chemotherapy in ovarian cancer.
In collaboration with colleagues in the Institute of Cancer at Barts and the London, Queen Mary School of Medicine and Dentistry, we are developing novel treatments for ovarian cancer, including new antibodies and gene therapy.
Head and neck cancer
Lung cancer and mesothelioma
Skin cancer and melanoma